Elicera Therapeutics: PhD thesis describing the iTANK-platform awarded best of the year 2021 in Sweden in the field of gene and cell therapy
Jing Ma's PhD thesis describes the development of Elicera's iTANK-platform and the upcoming CAR T-cell study in treatment of B-cell lymphoma. Jing Ma was invited to present her work at the SSGCT board meeting on October 11, 2022.
Jing Ma was supervised by Elicera Therapeutic's co-founder, Associate Professor Di Yu.